UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience

Nuclear medicine and biology, 2022-01, Vol.104-105, p.53-64

2022

Volltextzugriff (PDF)

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide

Pharmaceutics, 2021-06, Vol.13 (7), p.980

2021

Volltextzugriff (PDF)

Fc-engineered monoclonal antibodies to reduce off-target liver uptake

EJNMMI research, 2023-09, Vol.13 (1), p.81-6, Article 81

2023

Volltextzugriff (PDF)

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Clinical cancer research, 2019-01, Vol.25 (2), p.868-880

2019

Volltextzugriff (PDF)

Efficient Synthesis of 1,4,7-Triazacyclononane and 1,4,7-Triazacyclononane-Based Bifunctional Chelators for Bioconjugation

European journal of organic chemistry, 2014-12, Vol.2014 (35), p.7831-7838

2014

Volltextzugriff (PDF)

Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging

ACS omega, 2019-02, Vol.4 (2), p.2637-2648

2019

Volltextzugriff (PDF)

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

Journal of Nuclear Medicine, 2018-06, Vol.59 (6), p.878-884

2018

Volltextzugriff (PDF)

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2

Journal of Nuclear Medicine, 2018-07, Vol.59 (7), p.1020-1027

2018

Volltextzugriff (PDF)

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

Chemical communications (Cambridge, England), 2019-01, Vol.55 (10), p.1394-1397

2019

Volltextzugriff (PDF)

Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting

Journal of Nuclear Medicine, 2024-10, Vol.65 (10), p.1564-1570

2024

Volltextzugriff (PDF)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Pharmacology & therapeutics (Oxford), 2022-05, Vol.233, p.108022-108022, Article 108022

2022

Volltextzugriff (PDF)

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell linesThis article is dedicated to Prof. Ernesto Carmona (Universidad de Sevilla-CSIC) on the occasion of his 70th birthday.Electronic supplementary information (ESI) available: Experimental section (synthesis and characterization of all compounds and antibody gold conjugates), NMR and MS-ESI spectra for new compounds 1-4 and their stability studies by NMR spectroscopy; HPLC, MAL

2019-01

Volltextzugriff (PDF)

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines (This article is dedicated to Prof. Ernesto Carmona (Universidad de Sevilla-CSIC) on the occasion of his 70th birthday.)

Chemical communications (Cambridge, England), 2019-01, Vol.55 (10), p.1394-1397

2019

Volltextzugriff (PDF)

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy

Journal of Nuclear Medicine, 2023-12, Vol.64 (12), p.1956-1964

2023

Volltextzugriff (PDF)

a-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

The Journal of nuclear medicine (1978), 2018-06, Vol.59 (6), p.878

2018

Volltextzugriff (PDF)

A Rapid Bead Based Radioimmunoassay for the Determination of Target Binding Fraction and Quality Control of Radiopharmaceuticals

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer

European journal of medicinal chemistry, 2022-09, Vol.239, p.114504-114504, Article 114504

2022

Volltextzugriff (PDF)

From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience5

Nuclear medicine and biology, 2022-01, Vol.104/105, p.53

2022

Volltextzugriff (PDF)

In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4

Nuclear medicine and biology, 2023-05, Vol.120-121, p.108335, Article 108335

2023

Volltextzugriff (PDF)

A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals

Nuclear medicine and biology, 2019-04, Vol.71, p.32-38

2019

Volltextzugriff (PDF)

Preclinical optimization of antibody‐based radiopharmaceuticals for cancer imaging and radionuclide therapy—Model, vector, and radionuclide selection

Journal of labelled compounds & radiopharmaceuticals, 2018-07, Vol.61 (9), p.611-635

2018

Volltextzugriff (PDF)

AMD3100: A Versatile Platform for CXCR4 Targeting (68)Ga-Based Radiopharmaceuticals

Bioconjugate chemistry, 2016-03, Vol.27 (3), p.752-761

2016

Volltextzugriff (PDF)

Leveraging ^sup 225^Ac-pretargeted radioimmunotherapy for application in pancreatic ductal adenocarcinoma therapy

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.540

2018

Volltextzugriff (PDF)

Leveraging 225Ac-pretargeted radioimmunotherapy for application in pancreatic ductal adenocarcinoma therapy

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.540

2018

Volltextzugriff (PDF)

New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities

Dalton transactions : an international journal of inorganic chemistry, 2015-03, Vol.44 (11), p.5004-5016

2015

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(42)
Buchkapitel
(1)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(12)
Life Sciences & Biomedicine
(12)
Radiation Therapy
(9)
Tumors
(9)
Antibodies
(8)
Animals
(7)
Radioisotopes
(7)
Cancer
(6)
Radiology, Nuclear Medicine & Medical Imaging
(6)
Xenotransplantation
(6)
Clinical Trials
(5)
Imaging
(5)
Life Sciences
(5)
Mice
(5)
Cell Line, Tumor
(4)
Chemistry
(4)
Cytotoxicity
(4)
Female
(4)
Injection
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide

Fc-engineered monoclonal antibodies to reduce off-target liver uptake

Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Efficient Synthesis of 1,4,7-Triazacyclononane and 1,4,7-Triazacyclononane-Based Bifunctional Chelators for Bioconjugation

Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 2

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines

Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them

Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell lines (This article is dedicated to Prof. Ernesto Carmona (Universidad de Sevilla-CSIC) on the occasion of his 70th birthday.)

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy

a-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1

A Rapid Bead Based Radioimmunoassay for the Determination of Target Binding Fraction and Quality Control of Radiopharmaceuticals

Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer

From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience5

In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4

A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals

Preclinical optimization of antibody‐based radiopharmaceuticals for cancer imaging and radionuclide therapy—Model, vector, and radionuclide selection

AMD3100: A Versatile Platform for CXCR4 Targeting (68)Ga-Based Radiopharmaceuticals

Leveraging ^sup 225^Ac-pretargeted radioimmunotherapy for application in pancreatic ductal adenocarcinoma therapy

Leveraging 225Ac-pretargeted radioimmunotherapy for application in pancreatic ductal adenocarcinoma therapy

New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities

Suchergebnisse filtern